Muscle tablets

This web site is intended for Australian residents and is not a substitute for independent professional advice. Information and interactions contained in this Web site are for information purposes only and are not intended to be used to diagnose, treat, cure or prevent any disease. Further, the accuracy, currency and completeness of the information available on this Web site cannot be guaranteed. Dr Me Pty Ltd, its affiliates and their respective servants and agents do not accept any liability for any injury, loss or damage incurred by use of or reliance on the information made available via or through myDr whether arising from negligence or otherwise. See Privacy Policy and Disclaimer .

Delivery options
Order & Collect
Free next day collection from your choice of over 2,200 Boots stores

Standard Delivery
£ or free when you spend £45 or more

Next Day Delivery
£ - place before 7pm for delivery the next day. Excludes weekends

Named Day Delivery
£ - choose a weekday within the next 14 days for delivery

Saturday Delivery
£ - usually delivered between 7am - 1pm

For more information see our delivery help or view our returns policy .

The pharmacokinetics of dalfampridine was studied in 9 male and 11 female subjects with varying degrees of renal function. Elimination of the drug is significantly correlated with the creatinine clearance. Total body clearance of dalfampridine was reduced by about 45 % in patients with mild renal impairment (CrCl 51-80 mL/min), by about 50% in patients with moderate renal impairment (CrCl = 30-50 mL/min), and by about 75% in patients with severe renal impairment (CrCl <30 mL/min). The terminal half-life of dalfampridine is about times longer in patients with severe renal impairment but is not prolonged in patients with mild or moderate renal impairment.

Muscle tablets

muscle tablets


muscle tabletsmuscle tabletsmuscle tabletsmuscle tabletsmuscle tablets